Boston Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.58M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.34M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$431K |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$171K |
| 5 |
Verizon
VZ
|
+$46.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$4.22M |
| 2 |
Apple
AAPL
|
+$2.19M |
| 3 |
The Mosaic Company
MOS
|
+$1.73M |
| 4 |
Intel
INTC
|
+$1.58M |
| 5 |
ConocoPhillips
COP
|
+$1.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.1% |
| 3 | Consumer Staples | 13.8% |
| 4 | Industrials | 10.73% |
| 5 | Communication Services | 9.11% |
Similar funds
Boston Research & Management's Q1 2020 Portfolio in Review
As of Q1 2020, Boston Research & Management held 101 positions worth $199M, down 25% from $267M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Boston Research & Management withdrew a net $19.4M in Q1 2020, closing 9 positions and reducing 52 holdings. Its most notable exit was The Mosaic Company, an estimated $1.73M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Boston Research & Management added an estimated $2.58M to iShares Core S&P 500 ETF.
- Boston Research & Management added most to iShares Core S&P 500 ETF in Q1 2020, an estimated $2.58M increase.
- Boston Research & Management's biggest Q1 2020 reduction was RTX Corp, cutting an estimated $4.22M.
- Boston Research & Management fully exited The Mosaic Company in Q1 2020, selling an estimated $1.73M.
- Boston Research & Management's ten largest holdings make up 30% of its $199M portfolio in Q1 2020.
- Boston Research & Management opened 0 new positions and closed 9 in Q1 2020.
- Boston Research & Management's portfolio value fell 25% quarter-over-quarter to $199M.
Based on Boston Research & Management's 13F filing for Q1 2020, filed 8 May 2020.